Company Search:
Advanced Search
Sponsored Links
Dottikon ES Holding AG Company Snapshot
Dottikon ES Holding AG operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dottikon ES Holding AG with three other pharmaceutical manufacturers in Europe: Vectura Group PLC of the United Kingdom (2016 sales of £72.00 million [US$87.70 million] of which 100% was Pharmaceutical Prod), Quantum Pharma PLC of the United Kingdom (£69.99 million [US$85.25 million] of which 85% was Specials), and Allergy Therapeutics PLC which is also based in the United Kingdom (£48.51 million [US$59.09 million] ).

Sales Analysis. During the year ended March of 2016, sales at Dottikon ES Holding AG were 121.43 million Swiss Francs (US$122.66 million). This is an increase of 25.8% versus 2015, when the company's sales were 96.49 million Swiss Francs. This was the fifth consecutive year of sales increases at Dottikon ES Holding AG (and since 2011, sales have increased a total of 52%). Sales of Pharma Products saw an increase of 37.8% in 2016, from 79.07 million Swiss Francs to 108.93 million Swiss Francs. Not all segments of Dottikon ES Holding AG experienced an increase in sales in 2016: sales of Fine Chemicals fell 34.4% to 8.95 million Swiss Francs. Dottikon ES Holding AG also experienced decreases in sales in Recycling and Waste (down 6.0% to 3.55 million Swiss Francs) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Dottikon ES Holding AG
  Stock Performance Chart for Dottikon ES Holding AG
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 389.75
(Figures in Swiss Francs)
1 Week 2.0%   13 Weeks -1.6%  
4 Weeks -9.4%   52 Weeks 99.7%  
Dottikon ES Holding AG Key Data:
  Ticker: DESN Country: Switzerland
  Exchanges: ZHR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 121,433,000
(Year Ending Jan 2017).
Employees: 495
  Currency: Swiss Francs Market Cap: 486,210,397
  Fiscal Yr Ends: March Shares Outstanding: 1,247,493
  Share Type: Namenaktie Closely Held Shares: 1,070,337
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.